Table 5 Data completion for research outcomes
Standard | Telehealth | Total | |
|---|---|---|---|
Total randomised | 31 (100%) | 32 (100%) | 63 (100%) |
Consent | |||
Valid consent | 25 (80.6%) | 28 (87.5%) | 53 (84.1%) |
Missing consent | 6 (19.4%) | 4 (12.5%) | 10 (15.9%) |
Dropped out | |||
Prior to 8-week completion | 0 (0.0%) | 5 (15.6%) | 5 (7.9%) |
Prior to 8-month completion | 1 (3.2%) | 1 (3.1%) | 2 (3.2%) |
Intervention length | |||
8 weeks | 20 (64.5%) | 20 (62.5%) | 40 (63.5%) |
Less than 8 weeks | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
More than 8 weeks | 5 (16.1%) | 3 (9.4%) | 8 (12.7%) |
Baseline SGRQ | |||
Valid | 16 (51.6%) | 14 (43.8%)* | 30 (47.6%) |
Invalid** | 5 (16.1%) | 3 (9.4%) | 8 (12.7%) |
Missing | 4 (13.0%) | 7 (21.9%) | 11 (17.5%) |
8-week SGRQ | |||
Valid | 11 (35.5%) | 15 (46.9%) | 26 (41.3%) |
Invalid | 2 (6.5%) | 1 (3.1%) | 3 (4.8%) |
Missing | 12 (38.7%) | 7 (21.9%) | 19 (30.2%) |
6-month SGRQ | |||
Valid | 8 (25.8%) | 5 (15.6%) | 13 (20.6%) |
Invalid | 1 (3.2%) | 1 (3.1%) | 2 (3.2%) |
Missing | 5 (16.1%) | 5 (15.6%) | 10 (15.9%) |
Had not reached time point by Jan12 | 10 (32.3%) | 11 (34.4%) | 21 (33.3%) |
Participants with valid baseline & 8-week SGRQ data | 9 (29.0%) | 12 (37.5%) | 21 (33.3%) |
Participants with valid baseline, 8-week & 6-month SGRQ data | 2 (6.5%) | 2 (6.3%) | 4 (6.3%) |